Patient-Centered Framework for Rehabilitation Research in Outpatient Settings

Conducting high-quality clinical research is dependent on merging scientific rigor with the clinical environment. This is often a complex endeavor that may include numerous barriers and competing interests. Overcoming these challenges and successfully integrating clinical research programs into clinical practice settings serving rehabilitation outpatients is beneficial from both a logistical perspective (eg, supports efficient and successful research procedures) and the establishment of a truly patient-centered research approach. Leveraging our experience with navigating this research-clinical care relationship, this article (1) proposes the Patient-Centered Framework for Rehabilitation Research, a model for integrating patient-centered research in an outpatient clinical setting that incorporates a collaborative, team-based model encompassing patient-centered values, as well as strategies for recruitment and retention, with a focus on populations living with disabilities or chronic diseases; (2) describes application of this framework in a comprehensive specialty multiple sclerosis center with both general strategies and specific examples to guide adaptation and implementation in other settings; and (3) discusses the effect of the framework as a model in 1 center, as well as the need for additional investigation and adaptation for other populations. The 5 interconnected principles incorporated in the Framework and which prioritize patient-centeredness include identifying shared values, partnering with the clinical setting, engaging with the population, building relationships with individuals, and designing accessible procedures. The Patient-Centered Framework for Rehabilitation Research is a model presented as an adaptable roadmap to guide researchers in hopes of not only improving individual patients’ experiences but also the quality and relevance of rehabilitation research as a whole. Future investigation is needed to test the Framework in other settings.     

Percutaneous management of lymphatic fluid collections

Eight lymphatic fluid collections were drained percutaneously. There were no immediate or late complications. Seven patients had follow-up; 1 required surgical drainage of a residual or recurrent lymphocele, and another had reaccumulated fluid in a lymphocele which was detected on autopsy. The remaining lymphatic collections responded to percutaneous drainage. Percutaneous drainage is safe and can be an effective tool in the management of lymphatic collections.     

结合计算法和单一酶免法测定血清游离睾酮结果比较

目的　探寻测定血清游离睾酮 (FT)浓度的准确方法。　方法　 12 9例 45岁以上健康男性 ,按年龄分为 4组 ,收集血清标本 -40℃冻存。酶标免疫方法同批测定FT ,同时测定总睾酮 (T)和性激素结合球蛋白 (SHBG)并代入Vermeulen公式计算 :FT =T -2 3 .43FTSHBG -(T -2 3 .43FT) × 10 - 9mol/L。对两种方法测定结果进行统计学比较。　结果　 12 9例标本中酶免法FT为 (46.69± 2 1.79)pmol/L ,计算法为 (3 96.3 0± 3 17.0 4)pmol/L ,t =13 .0 1,P <0 .0 1,差异有非常显著性意义。两种方法测定FT浓度各年龄组间差异均有非常显著性意义 (P <0 .0 1) ;与年龄相关分析差异均有非常显著性意义 (P <0 .0 1) ,相关程度计算法大于酶免法。FT/T平均百分数酶免法为 0 .2 3 % ,计算法为 1.42 %。　结论　结合计算法检测FT浓度较酶免法更科学、正确 ,更适用于老年男子部分性雄激素缺乏综合征 (PADAM )的诊断     

老年髋部骨折术后患者康复需求程度与康复状况调查

目的了解老年髋部骨折术后患者康复需求程度、需求满足度与康复状况的关系.方法上门随访82例老年髋部骨折术后患者家庭康复现状和康复需求情况.结果康复需求10个维度中他人支持、康复信息及功能训练指导位居前3位;需求程度与生理功能、躯体功能和社会功能有关(P＜0.05,P＜0.01);与髋关节功能评分中的疼痛程度、上楼梯、穿鞋袜和行走距离4个方面有关(P＜0.05,P＜0.01).结论出院后定期给予针对性的康复训练指导和健康教育是患者迫切的需求;康复需求程度高者,相应需求满足率低,其生活质量及髋关节功能恢复应成为干预的重点.     

测胎儿器官重量探讨其生长发育规律

根据1022例新鲜胎尸的不同受精龄与体重，十项重要器官（心、肝、脾、左右肺、左右肾、左右肾上腺、胸腺等）的重量进行测量，将所测得的原始数据输入到IBM-PC/XT微型计算机内进行数据处理。探讨胎儿生长发育的基本规律。结果：（1）建立了胎儿体重与胎龄之间的推算式；（2）建立了胎儿各重要器官重量与胎龄之间的推算式；（3）建立了胎儿体重每月平均增长量与胎龄之间的推算式；（4）按胎儿体重每月平均增长量，用有序聚类分析方法，将胎儿生长发育过程划分为三个阶段。     

青岛市居民就诊单位选择影响因素的多项式Logistic回归分析

①目的研究影响青岛市城乡居民选择就诊单位的因素。②方法采用多项式Logistic回归分析法，分析影响青岛市城乡居民选择就诊单位的主要因素。③结果影响市区病人选择就诊单位的主要因素是医疗保健制度和居民健康状况．农村病人的主要影响因素是家庭收入、健康状况和受教育程度。④结论居民就诊单位选择受多种因素的影响，建议加快医疗保健制度的改革．完善医疗保健制度。     

Recall of medication during pregnancy: Validity and accuracy of an adjusted questionnaire

Objective — To study the validity and accuracy of an adjusted questionnaire on medical drug use during pregnancy eight years after the pregnancy. Methods — The ability of a questionnaire on medication during pregnancy to detect actual use (= sensitivity) was tested against information collected 8 years previously (in 1983–1984) from 473 women with high-risk pregnancies who delivered at the University Hospital Nijmegen, the Netherlands. Results — For separate drug groups, the sensitivity varied between 5% and 91%. The timing of use was recalled moderately well. Although specific questions on drug groups did improve the sensitivity as compared to an earlier questionnaire, the improvement was not enough to make the questionnaire valid. High maternal education, low birth weight, low gestational age and a low 5-min Apgar score were related to better recall. The sensitivity of the questionnaire depended on the behavioural score of the child, implying recall bias. Conclusion — Questionnaire data on drug use during pregnancy obtained eight years after delivery are not a valid source of information.     

炎症性肠病患者生存质量与其应对方式和社会支持的相关性

目的探讨炎症性肠病(IBD)患者的生存质量及其与应对方式和社会支持的相关性.方法应用中文IBD问卷(IBDQ)、简明健康调查问卷(SF-36)、简易应对方式问卷、社会支持评定量表对71例IBD患者(IBD组)进行调查,并与103名正常人(对照组)进行比较.结果IBD患者SF-36及各维度评分显著低于对照组(均P＜0.01),积极应对评分亦显著低于对照组(P＜0.01).IBD患者的积极应对和社会支持与其生存质量呈正相关(P＜0.05,P＜0.01),消极应对与生存质量呈负相关(P＜0.05,P＜0.01).结论IBD患者的生存质量水平较低,良好的应对方式和社会支持能提高其生存质量.     

产后抑郁症相关因素调查研究

目的探讨产后抑郁症的相关因素.方法采用分层整群抽样方法,对长沙市4所医院300例产后6周复查的初产妇进行Edinburgh产后抑郁量表与自编问卷调查.结果产后抑郁症的发生率为17.3%;产妇年龄、婚姻状况、教育程度与产后抑郁症无关(均P＞0.05),分娩疼痛承受力、分娩方式、新生儿性别、母婴同室、母乳喂养为产后抑郁症的影响因素(P＜0.05、P＜0.01),且分娩方式是产后抑郁症的危险因素,分娩疼痛承受力与母婴同室是保护因素.结论产后抑郁症发生率较高,其影响因素应引起产科工作人员的重视.     

Requiring Consent vs. Waiving Consent for Medical Records Research: A Minnesota Law vs. the U.S. (HIPAA) Privacy Rule

The use of medical records in research can yield information that is difficult to obtain by other means. When such records are released to investigators in identifiable form, however, substantial privacy and confidentiality risks may be created. These risks become more common and more serious as medical records move to an electronic format. In 1996, the state of Minnesota enacted legislation with respect to consent requirements for the use of medical records in research. This legislation has been widely criticized because--it is claimed--it creates an unnecessary impediment to research. In this article, we show that these arguments rest upon misinterpretation and/or misrepresentation of the 1996 legislation. A consent requirement had actually been present in Minnesota since 1976 (though codified in a patient rights statute rather than a privacy statute). The 1996 law does not require specific consent, as often claimed, but rather only a general authorization. The campaign against the Minnesota legislation appears to have been motivated by concern with respect to the then impending federal privacy rule. The HIPAA rule, as enacted, is in fact less stringent with respect to consent than the Minnesota consent law. On the other hand, the Minnesota consent law has not been effectively applied or enforced. As we change the way we manage sensitive medical information, new efforts are needed to provide protection against the confidentiality risks in research. Patient consent is an important tool in this regard. New instrumentalities are needed to solicit and document consent.